BEAM-201

· Beam Therapeutics Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BEAM-201, covering 2025-01-13 to 2025-01-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study Evaluating the Safety and Efficacy of BEAM-201 in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LL) [Phase 1, Phase 2]

See pricing